Literature DB >> 12191633

Epigenetics wins over genetics: induction of differentiation in tumor cells.

Joseph Lotem1, Leo Sachs.   

Abstract

Malignant cells are genetically abnormal, but can the malignant phenotype revert to a non-malignant phenotype without correcting these genetic abnormalities? It has been found that this reversion can be achieved by reprogramming tumor cells by epigenetic changes induced by differentiation. The epigenetic suppression of malignancy by inducing differentiation bypasses the genetic abnormalities in tumor cells. Studies with myeloid leukemic cells have shown that some leukemic cells can be induced to differentiate by cytokines that control normal hematopoiesis, and that myeloid leukemic cells resistant to normal cytokines can be induced to differentiate by compounds that use alternative differentiation pathways. The epigenetic reprogramming of tumor cells by inducing differentiation has also been found with other types of tumors and can be used for tumor therapy. By this reversion of the malignant to non-malignant phenotype, epigenetics wins over genetics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12191633     DOI: 10.1016/s1044-579x(02)00054-8

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  25 in total

1.  Blocking p55PIK signaling inhibits proliferation and induces differentiation of leukemia cells.

Authors:  G Wang; Y Deng; X Cao; S Lai; Y Tong; X Luo; Y Feng; X Xia; J Gong; J Hu
Journal:  Cell Death Differ       Date:  2012-06-22       Impact factor: 15.828

Review 2.  Leukaemia 'firsts' in cancer research and treatment.

Authors:  Mel Greaves
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

3.  Pioneer of hematopoietic colony-stimulating factors: Leo Sachs (1924-2013).

Authors:  Michael Sela; Yoram Groner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

4.  Human cancers overexpress genes that are specific to a variety of normal human tissues.

Authors:  Joseph Lotem; Dvir Netanely; Eytan Domany; Leo Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-08       Impact factor: 11.205

5.  Towards a systemic paradigm in carcinogenesis: linking epigenetics and genetics.

Authors:  Ernesto Burgio; Lucia Migliore
Journal:  Mol Biol Rep       Date:  2015-04       Impact factor: 2.316

6.  Induction in myeloid leukemic cells of genes that are expressed in different normal tissues.

Authors:  Joseph Lotem; Hila Benjamin; Dvir Netanely; Eytan Domany; Leo Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

7.  p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.

Authors:  Jenny S L Ho; Weili Ma; Daniel Y L Mao; Samuel Benchimol
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 8.  The molecular programme of tumour reversion: the steps beyond malignant transformation.

Authors:  Adam Telerman; Robert Amson
Journal:  Nat Rev Cancer       Date:  2009-01-30       Impact factor: 60.716

Review 9.  Tumor reversion: correction of malignant behavior by microenvironmental cues.

Authors:  Paraic A Kenny; Mina J Bissell
Journal:  Int J Cancer       Date:  2003-12-10       Impact factor: 7.396

10.  Inhibition of p53-induced apoptosis without affecting expression of p53-regulated genes.

Authors:  Joseph Lotem; Hilah Gal; Rachel Kama; Ninette Amariglio; Gideon Rechavi; Eytan Domany; Leo Sachs; David Givol
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.